Elizabeth Ditty
3PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster
|Sep 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.Susan M Clardy, Alex Uttard, Bingfan Du
|Jun 09, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.Dorin Toader, Shawn P Fessler, Scott D Collins
Pageof 1
Frequent Collaborators
3 joint publications
Dorin Toader
3 joint publications
Ling Xu
3 joint publications
Kalli C Catcott
3 joint publications
Marc Damelin
3 joint publications
Timothy B Lowinger
2 joint publications
Stephen P Bradley
2 joint publications
Scott D Collins
2 joint publications
Caitlin Routhier
2 joint publications
Liuliang Qin
2 joint publications
Jeremy R Duvall
